ʻO Retatrutide a me ka GLP-1 Grey Market: No ke aha ʻo Peptide Identity wale nō ke kumu hoʻomaka

Pane wikiwiki

ʻO ka pākēneka maʻemaʻe hoʻokahi loulou ma kahi kaulahao, a ʻo ke kaulahao ka mea a ka mea loiloi e loiloi ai. A certificate that reports 99% by HPLC area tells you how much of the u…

No ke aha i hiki ʻole ai i kahi helu maʻemaʻe ke pane i ka nīnau ʻike ʻike Retatrutide Peptide

Mea Hoʻolako Peptide Pegylation Beta Endorphin Pane ka maʻemaʻe a me ka ʻike i nā nīnau like ʻole, a hoʻokahi wale nō o lākou e pili ana inā loaʻa iā ʻoe ka molekala kūpono. Nīnau ka hoʻomaʻemaʻe ʻāpana-pakeneka i ka nui o ka mea e hoʻopaʻa ai i ka UV ka piko nui. Nīnau ʻo Identity inā ʻo kēlā peak ka mole āu i kauoha ai, a me I Q2(R2) mālama i nā pilikia ʻelua e like me nā pilikia hōʻoia ʻokoʻa: Pono e hōʻike ka hoʻāʻo ʻike i ka hiki ke ʻike i ka analyte "ma muli o nā ʻano kūʻokoʻa o kona ʻano molekala,” a me nā kaha kuhikuhi, ka pololei a me ka pololei e like me ka mea maʻamau ʻaʻole i koi ʻia no ka ʻike akā koi ʻia no nā hoʻokolohua quantitative haumia (I Q2(R2), 2023, hooponoponoia 2025). ʻIke mākou he mea nui ka ʻokoʻa ma mua o kahi peptide noiʻi maʻamau. ʻO ke kūlana o ka FDA, ʻaʻole i ʻike ʻia ka retatrutide i palekana a maikaʻi no kekahi ʻano, no laila ʻaʻohe mea ma luna o kāu hoʻāʻo ʻana i hoʻokumu i ke ʻano o ka mea. ʻO ka maʻemaʻe peptide vs ka ʻike ʻaʻole ia he quibble semantic; ʻo ia ka ʻokoʻa ma waena o kahi helu i hiki ke hana hou ʻia a me kahi mole e hiki ke hoʻopaʻa ʻia.

ʻO Retatrutide a me ka GLP-1 Grey Market: No ke aha ʻo Peptide Identity wale nō ke kumu hoʻomaka

Ki Takeaway: Nīnau ka hoʻomaʻemaʻe i ka nui o ka mea e hoʻopaʻa ai i ka UV ka piko nui; Nīnau ʻo identity inā ʻo kēlā peak ka mole āu i kauoha ai.

Ka mea a ka FDA i ʻōlelo maoli ai, a no ke aha i hoʻohana ʻole ai i ka noiʻi wale nō

ʻAʻole hana ka lepili noiʻi-hoʻohana-wale i kahi ʻano maikaʻi, a ua ʻōlelo ka FDA ma ke kākau ʻana. In ʻo Malaki o ka ʻoihana 2026 leka iā Gram Peptides, ua hōʻole pololei ka ʻoihana i ka hōʻole: "ʻOiai nā ʻōlelo e pili ana i kāu hōʻailona huahana ke kūʻai aku nei i kāu huahana 'Research Use Only'… ʻike ʻia nā hōʻike i loaʻa mai kāu pūnaewele i manaʻo ʻia kāu huahana e lilo i mau lāʻau no ka hoʻohana kanaka." ʻAʻole hoʻokahi wale nō ka ʻike. He leka ʻelua ma hope o ʻelima mahina, kau ʻia 24 ʻAukake 2026, Ua haʻi hou ʻo ia a haʻi i kahi "calculator peptide" ma ke ʻano he "mea e hoʻomākaukau ai i kahi lāʻau injectable no ka hoʻokele kanaka."

ʻO Retatrutide a me ka GLP-1 Grey Market: No ke aha ʻo Peptide Identity wale nō ke kumu hoʻomaka

Lā palapala

Loaʻa

Hōʻike ʻia nā hōʻike pūnaewele

31 Malaki 2026

Gram Peptides (MARCS-CMS 721806)

Kūʻē ka lepili RUO e ka ʻike pūnaewele; kūʻai aku i ka wai bacteriostatic

24 ʻAukake 2026

ʻO Peptide Partners LLC (735063)

Hōʻole ʻia ka footnote RUO; peptide calculator ma ke ʻano he mea hoʻomākaukau

24 ʻAukake 2026

NuScience Peptides LLC (733652)

ʻO ka ʻimi hoʻohana like

ʻElima mau leka i hoʻopuka ʻia i ka lā hoʻokahi o ʻAukake hāʻawi i kēlā me kēia mea loaʻa 15 lā e pane ai, a ua hoouna okoa aku ke keena 30 nā leka i Malaki i nā hui olakino e kūʻai aku ana i nā GLP-1 hui pū ʻia. No ka mea kūʻai hale keʻena, haiki ka heluhelu pono: ʻAʻole haʻi ka lepili iā ʻoe e pili ana i ke kumu a i ʻole ka hoʻāʻo ʻana, a wehewehe ka FDA i nā huahana i kūʻai ʻia ma kēia ʻano he "ʻike ʻole ʻia." Hoʻomaka ka pilikia palapala o ka mākeke hina GLP-1 ma laila.

He aha ka HPLC Maʻemaʻe Paneka, a me ka mea e waiho ana

ʻO kahi helu hoʻomaʻemaʻe ʻāpana-pakeneka e ana i ka mahele nui o ka hōʻailona UV i hoʻohui ʻia, ʻaʻohe mea ʻē aʻe. ʻAʻole hiki iā ia ke ʻike i ka ʻoki ʻana i ka co-eluting i ka manawa paʻa like me ka piko nui, ʻAʻole ia e ʻōlelo e pili ana i ka nui o ka nui o ka vial he peptide. A 2026 loiloi ma ka Journal of Pharmaceutical Investigation ka wehewehe ʻana i ka maʻiʻo peptide net e like me ka pākēneka o ka nui o nā peptides e pili ana i nā mea ʻē aʻe a pau, me ka wai, nā iona kūʻē, nā koena solvents a me nā paʻakai, helu pinepine ʻia e ke koena nuipaʻa, a me nā ʻōlelo e hōʻike ʻia nā hopena hoʻokolohua ma kahi anhydrous, kumu kūʻē ion-free kumu. Hiki i nā hue ʻelua ke heluhelu 99% maʻemaʻe wahi a ʻokoʻa loa i ka nui o ka peptide no kēlā me kēia vial.

ʻO Retatrutide a me ka GLP-1 Grey Market: No ke aha ʻo Peptide Identity wale nō ke kumu hoʻomaka

Ana ana

ʻO ka mea e hōʻike nei

ʻO ka mea i hōʻike ʻole ʻia

Maʻemaʻe pākēneka

ʻO ka mahele nui o ka hōʻailona UV i hoʻohui ʻia

ʻIkepili; nuipa peptide; haumia ʻike ʻole ʻia

ʻO ka maʻiʻo peptide pūnaewele

Māhele peptide o ka huina hoʻohālike nuipa (kaulike lehulehu)

Kaʻina; hale haumia

Maʻiʻo kūʻē

ʻAno paʻakai koena, e.g. TFA

Inā paha i manaʻo ʻia ka counterion

ʻAno wai

Ke koena wai

ʻO nā mea āpau e pili ana i ka peptide ponoʻī

Mālama ka loiloi like i ka trifluoroacetic acid ma ke ʻano he hihia: Hoʻohana maʻamau ʻia ʻo TFA i ka hana peptide synthetic a hiki ke loaʻa ma ke ʻano he counter ion ma ke kahua o ka lāʻau., akā, i ka hapanui o nā hihia, ʻaʻole ia ka mea i manaʻo ʻia ʻo ka counter ion hope loa a mālama ʻia ma ke ʻano he koena e pili ana i ke kaʻina hana. He palapala hōʻike e hōʻike ana i ka maʻemaʻe me ka ʻole o ka ʻike, Ua pane ka ʻikepili counterion a me ka wai i kahi nīnau haiki ma mua o ka nīnau a ka mea loiloi.

He aha ka Retatrutide Peptide Identity hōʻoia e koi ai ma mua o kahi helu lehulehu

He mea pono ka intact mass akā ʻaʻole ʻo ia wale nō ka hoʻokumu ʻana i ke kaʻina holoʻokoʻa a i ʻole stereochemistry. E koho i nā ala hoʻohui no nā nīnau hoʻolālā i hoʻoholo ʻole ʻia; ʻaʻole ʻo ia wale nō ka hoʻolālā ʻike.

ʻO ka hoʻopuka paʻi ʻana o USP i nā kūlana kuhikuhi peptide hōʻike i ke ʻano o ka hana: hoʻokumu ʻia ka ʻike e NMR, nuipaʻa spectrometry, Ka manawa mālama HPLC, ka nānā ʻana o ka waikawa amino a me ka chiral GC-MS pū kekahi, me ka ho'āʻo kūʻē i ka ion a me ke koena ma ka ʻā, a me ka maʻiʻo i hāʻawi ʻia e ke koena nui ma waena o nā laboratories (McCarthy et al., 2023). Hōʻike ka pepa ʻike i ka mole "he peptide acylated hoʻokahi momona momona e hoʻohui i ka GCGR., GIPR, a me nā hana GLP-1R… i hana ʻia mai kahi peptide GIP” (ʻO Coskun et al., 2022), ʻo ia ke kiʻekiʻe o ka wehewehe ʻana i ke ʻano o ke kaʻina hoʻopaʻa hoʻonohonoho. ʻAʻole hiki i ka helu nui wale ke hoʻokaʻawale i ke kaʻina lipid i hoʻopaʻa pono ʻia mai kahi lipid piha ʻole o ka nui like..

ʻO wai nā mea haumia a me nā mokuʻāina kino e pili ana i kahi Triple Agonist

ʻO nā ʻaoʻao haumia no ka mea hana, no laila, ʻaʻole manaʻo ka hoʻohālikelike ʻana i kahi lepili e pili ana i kahi ʻaoʻao haumia. ʻO ka 2026 Hōʻike ka loiloi ʻaʻole hiki ke hoʻonui ʻia nā mea pili i ka peptide "a ua hōʻike ʻia nā ʻano like ʻole no ka liraglutide synthetic a me ka semaglutide ma muli o ka mea hana., me ka hoʻohui glycine a i ʻole ka pau ʻana o nā mea haumia i loko o ka lāʻau lapaʻau semaglutide a me nā huahana deprotection ʻole e like me tert-butylated semaglutide (ʻO Yang et al., 2026). No ka agonist triple, ʻO nā papa kūpono he ʻoki, deamidation a me nā huahana oxidation, ʻaʻole i piha i ka lipidation, koena pale-hui huahana a me racemized koena.

Aia ke kūlana kino ma ka papa inoa like. Nā ʻike oligomer o ka loiloi wehewehe oligomers o 2 i 10 nā molekala i loko o nā peptides me ka manaʻo pilikino kiʻekiʻe, me ka liraglutide a me ka semaglutide i hōʻike ʻia he 7-mer a me 3-mer. ʻAʻole i ana a wehe ʻole ʻia ka ʻāpana HPLC, ʻo ia ke kumu i komo ai ka chromatography i loko o ka pūʻolo. ʻAʻole i kūlike nā palena ʻae: ʻO ka loiloi e hōʻike ana i ka Ph. Eur. hoʻonohonoho i ka hōʻike ma luna 0.1%, ʻike ma luna 0.5% a me ka helu ma luna 1.0%, ʻoiai ka FDA e noʻonoʻo ana i nā palena haumia ʻole i hōʻike ʻia i kēlā me kēia hihia, a me ICH Q3A(R2) ʻAʻole pili pono i nā peptides.

⚠️ ʻŌlelo Aʻo: ʻO ka "Pharmacopeial Purity" kahi koi kumu ʻole ke ʻole ka inoa o ka mea kūʻai aku i ka monograph a me ke ʻano ma hope o ia..

He aha ka pūʻolo hoʻokuʻu palekana, a me ke ano o kona mau mooolelo

ʻO kahi pūʻolo hoʻokuʻu palekana he pūʻulu o nā moʻolelo e kuhikuhi ana kekahi i kekahi, ʻaʻole he hōʻiliʻili o nā PDF. Pono kēlā me kēia kahua e kapa i ke ʻano, ka mea kani, ka maʻamau kuhikuhi a me ka mea hoʻohana, i hiki i ka lua o ka loiloi ke huli i kekahi helu i ka ʻikepili maka.

Fi Mea kūʻai mai Stapled Peptides eld

ʻO ka mea e hōʻoiaʻiʻo ai

ʻO ka mea ʻaʻole ia

Helu helu ma kēlā me kēia ʻaoʻao

Aia nā moʻolelo i hoʻokahi pūʻulu

Ua hōʻike ʻia ka pūʻulu

Chromatogram me ka ID hana

Maʻemaʻe ma lalo o kahi ʻano i ʻōlelo ʻia Acetyl Hexapeptide-1

ʻIkepili o ka Peptodes piko nui

Hōʻike ʻike maʻamau

Kūʻē i ka hopena i ana ʻia

Ua kūpono ka maʻamau no kēia kaʻina

ʻIkepili ʻike (MS me ka palapala 'āina a i ʻole NMR)

Kaʻina a me ka haku mele ʻana ʻenehana Peptide

Stereochemistry ke ʻole e hoʻokomo ʻia ka hoʻokolohua chiral

ʻIke maʻiʻo a me ka counterion

ʻO ka nui peptide i kēlā me kēia hue

Paʻa

ʻO ka protocol paʻa a me nā manawa manawa

ʻO ka hoʻolālā ʻana o ke koi mālama ola

Nā hualoaʻa ma mua o nā manawa i hoʻāʻo ʻia

E koho i nā hōʻike kūpaʻa no ka hoʻohana ʻana i ka noiʻi maoli, kūlana mālama a me ke kahua. Hiki i nā hoʻolālā hoʻopaʻa inoa lāʻau lapaʻau ke hoʻomaopopo i ka hoʻolālā akā ʻaʻole ia he ʻumikūmālua mau mahina e pono ai no kahi noiʻi..

Ma kā mākou iho synthesis a me QC workflow ma MOL Changes, hana ʻia nā moʻolelo e nā mea hana e hana i ka ʻikepili: UHPLC me ka ʻike PDA no ka hoʻomaʻemaʻe ʻana, LC-MS e hoʻopaʻa i ka molecular mass a ʻike i nā kaʻina oki, nā huahana lipidation a i ʻole deamidation, me ICP-MS a me GC-MS e hoʻopiha ana i ke kiʻi elemental a me ke koena-solvent. ʻO kēlā ʻano hana ka mea e ʻike ʻia ai kahi palapala peptide o ka nānā ʻana ma mua o ka mea hoʻonaninani.

Kahi ʻAʻole Pono kēia Kūlana, a me ka mea e hana ai

He pipiʻi ka hōʻailona piha, a ʻaʻole hiki i kahi pūʻulu hoʻonaʻauao liʻiliʻi ke holo i ka GC-MS chiral a me ke kaulike lehulehu-laboratory ma kēlā me kēia pā. ʻO ke koho kūpono e hoʻonui i ka pūʻolo i ka hoʻoholo: ʻO ka ʻike ʻokoʻa piha ma ka hailona mua a ma kekahi hailona i hoʻohana ʻia no ka hopena i paʻi ʻia, a me ka puolo haiki o ka maemae, maʻiʻo, intact mass a me kahi ʻōlelo kūpaʻa no ka hana maʻamau. ʻO ka mea ʻaʻole pono e hoʻohaʻahaʻa ʻia ʻo ka traceability. Inā ʻaʻole hiki ke hoʻopaʻa ʻia ka chromatogram i loaʻa iā ʻoe i kahi ID kumu a me kahi maʻamau kuhikuhi, ʻO ka hana liʻiliʻi loa ka noi ʻana i kēlā mau mea ʻelua ma mua o ke kauoha ʻana i nā hoʻokolohua hou.

ʻO ka hoʻopaʻapaʻa ikaika loa ʻo ia ka ʻike piha ʻana o nā palapala mākeke hina, no laila ke koi ʻana i nā pepa pepa e uku aku i nā mea kūʻai aku ʻoi aku ka maikaʻi ma ka hana ʻana. ʻOiaʻiʻo kekahi hapa, a ʻo ia ke kumu i kūkulu ʻia ai ke kāʻei ma luna o nā ʻōlelo kuhikuhi ma mua o nā helu palapala. Makaainana o Mei 2026 loiloi hōʻike i nā palena o kekahi kumu hoʻokahi: ʻO kāna mau helu hāʻule kūʻai mai ka waihona hōʻike hoʻāʻo i hāʻawi ʻia e nā mea kūʻai aku, he laʻana i koho ʻia ponoʻī ʻaʻole hiki ke heluhelu ʻia ma ke ʻano he laha mākeke. E pili ana ka akahele like i kēlā me kēia pālākiō āu e hālāwai ai. E hoʻohana i ia mau helu e hoʻoholo i ka nui o ka hōʻoia e koi ai, aole loa i mea e pani ai.

No ke kōkua: Ma mua o ke koi ʻana i ka hoʻāʻo hou, E koi i ke ʻano ID a me ka maʻamau kuhikuhi ma hope o ka chromatogram i loaʻa iā ʻoe.

ʻO ke kānāwai hoʻoholo e pono i ka mea loiloi ke noi ma mua o ka ʻae ʻana i kahi hailona

E hoʻopili i nā pae hoʻohālike ʻelima i ka hoʻonohonoho, a kū i ka mea mua i hāʻule. He mea nui ke kaʻina no ka mea ʻaʻole hiki i ka helu hope ke hoʻopakele i kahi hāʻule mua: ʻAʻole waiwai ka ʻikepili kūpaʻa maikaʻi loa ma kahi peptide i ʻike ʻole ʻia.

Kūlana

Kūlana hele

Pono nā hōʻike

ʻIkepili

ʻElua mau ʻano orthogonal e ʻae me ka hoʻolālā i manaʻo ʻia

ʻO ka paʻa paʻa me ka palapala peptide, NMR a i ʻole ka nānā ʻana i ka waikawa amino

Maʻiʻo

Ua ʻōlelo ʻia ka ʻike peptide net, me ka counterion a me ka wai i helu ʻia

ʻO ke kaulike nui a i ʻole ka helu helu amino acid

Pilikino haumia

Hoʻopaʻa ʻia nā mea haumia i ʻōlelo ʻia a ʻike ʻole ʻia e kūʻē i kahi ala i kapa ʻia

Chromatogram me ke ʻano ID a me nā palena

Paʻa Hōʻike kūpono i ka mālama ʻana a me ka hoʻohana ʻana Nā kūlana i wehewehe ʻia, nā manawa a me nā ala kūpono; ka laulā o kekahi extrapolation i ʻōlelo ʻia

Nā moʻolelo

ʻO kēlā me kēia helu hiki ke ʻimi ʻia i ka ʻikepili maka ma lalo o kahi ala hoʻoponopono

Loaʻa nā moʻolelo pili pili i ka ALCOA a me ka ʻāpana 11 nā mana

ʻO kahi palapala peptide o ka nānā ʻana i hala i nā ʻelima a pau he palapala hiki i ka mea loiloi ke pale aku i kahi mea hana, he puke pai a i ʻole he papa loiloi ʻoihana. ʻO kahi mea i hāʻule i kekahi o lākou he wahi hoʻomaka no nā nīnau, aole he pane.

Nīnau pinepine

Hiki a 99% ke wehewehe nei ka palapala hōʻoia i kahi hue i ʻike hewa ʻia?

ʻAe. He pākēneka ʻāpana kēlā helu, no laila e wehewehe ana i ka nui o ka hōʻailona UV e noho ana ma lalo o ka piko nui, ʻaʻole he aha ka piko. ʻO kahi kaʻina hewa i elutes maʻemaʻe e heluhelu ʻia e like me 99% maʻemaʻe ke ʻole kahi ʻano ʻike orthogonal e holo pū me ia.

He mea maoli no ka hoʻonaʻauao kula liʻiliʻi?

ʻAʻole ma kēlā me kēia pā, a ʻaʻole pono. E mālama i ka pūʻolo orthogonal piha no ka hailona mua a no kekahi hailona e kū ana ma hope o ka hopena i paʻi ʻia, a hoʻohana i kahi ʻāpana haiki no ka hana maʻamau. ʻO ka mea nui, ʻo ka hoʻonohonoho liʻiliʻi e hoʻi i hope i kahi ID kumu a me kahi maʻamau kuhikuhi.

He aha ke kūlana apono o retatrutide?

ʻAʻole ia he lāʻau i ʻae ʻia, a ʻaʻole hiki ke hoʻohui ʻia. Ua ʻōlelo ka FDA ʻaʻole hiki ke hoʻohana ʻia ka retatrutide i ka hui ʻana ma lalo o ke kānāwai federal a ʻaʻole i ʻike ʻia he palekana a maikaʻi hoʻi no kekahi kūlana. (FDA, ʻike i kēia manawa 1 ʻOkakopa 2026). ʻO kahi hue i hōʻailona ʻia no ka hoʻohana noiʻi ʻana he mea noiʻi, aole he laau lapaau.

Pono e mālama ʻia nā loiloi mea kūʻai mai nā kahua hoʻāʻo e like me ka ʻikepili mākeke?

ʻAʻole. Loaʻa kēlā mau helu mai nā laʻana a nā mea kūʻai aku i koho ai e waiho, no laila wehewehe lākou i kēlā hui i koho ponoʻī a ʻaʻohe mea ākea. E mālama iā lākou ma ke ʻano he wikiwiki e nīnau i nā nīnau paʻakikī i kāu mea hoʻolako ponoʻī, ʻaʻole e like me ke kiʻi o ka mākeke hina GLP-1.

He aha kaʻu palapala e noi mua ai?

E hoʻomaka me ke ʻano kuhikuhi a me ke kumu o ke ana. Pono ke kūkulu hou ʻana i ka pūʻolo piha i ka ʻikepili maka kūpono, hoomakaukau ana, helu ʻana, nā mea hōʻike nui a me nā moʻolelo loiloi; ʻAʻole lawa nā mea ʻike ʻelua wale nō.

Ka hopena

ʻO ka pākēneka maʻemaʻe hoʻokahi loulou ma kahi kaulahao, a ʻo ke kaulahao ka mea a ka mea loiloi e loiloi ai. ʻO ke kūlana o ka FDA ʻaʻole hiki ke hoʻohana ʻia ka retatrutide i ka hui pū ʻana a ʻaʻole i hoʻopaʻa ʻia nā huahana GLP-1 i ʻae ʻole ʻia no ka palekana., ʻAʻole ʻo ka maikaʻi a i ʻole ka maikaʻi ke kumu e hoʻōki ai i ka nīnau ʻana i nā nīnau loiloi; ʻo ia ke kumu e nīnau ai iā lākou ma kahi ʻano paʻa. ʻIke mua, a laila ʻoluʻolu, a laila ʻike haumia, a laila kūpaʻa, alaila mooolelo, me ka hala ʻana o kēlā me kēia pae ma mua o ka noʻonoʻo ʻia ʻana. Ua ʻike mua ʻia ka neʻe ʻana o kēia ʻano i nā leka hoʻomaopopo: ʻaʻole hana hou ka lepili noiʻi-hoʻohana-wale ma ke ʻano he koi maikaʻi, a ua neʻe ka ukana palapala i ka mea kūʻai mai. Inā ʻoe e kuhikuhi nei i nā manaʻolana palapala analytical no kahi kaʻina maʻamau, hauʻoli kā mākou hui e kūkākūkā i nā mea e pono ai ka pūʻolo hoʻokuʻu no kāu noi.

Hōʻike ka mea hoʻopuka: Hāʻawi ʻo MOL Changes i nā lawelawe peptide a he hoihoi koʻikoʻi i kēia kumuhana. ʻO nā lālā lawelawe a me nā ʻōlelo hiki ke koi i nā mea hoʻolako; ʻO ka loaʻa a me ka hana ʻana no kahi kūkulu kikoʻī e koi i nā hōʻike kikoʻī o ka papahana.

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana